Liquid Biopsy Market Size, Share, Analysis, Trends and Forecast by 2027

 According to our new research study on “Liquid Biopsy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Services, Sample, Circulating Biomarker, Application, and End User,” the market is expected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. It is estimated that the market CAGR accounts for 9.9% during 2020–2027.


The global liquid biopsy market report highlights trends prevailing in the market and factors driving its growth. The liquid biopsy market is attributed to grow due to increasing prevalence of cancer, government and global health organizations initiatives. However, the low sensitivity of liquid biopsy is expected to restraint the global liquid biopsy market growth.

 

The global liquid biopsy market forecast is studied from 2019 to 2027. In 2019, North America accounted for the largest market share. The market growth in the region is attributed to the increasing number of orthopedic surgeries opted by geriatric population, growing developments for liquid biopsy by the companies, growing research for liquid biopsy, and others. APAC is expected to be the fastest-growing region among all other regions during the forecast period owing to the large cancer patient population, increasing number of research studies, growing government support, and increasing number of companies in this region.

 

Download the Free PDF Sample Here:

https://www.theinsightpartners.com/sample/TIPRE00003996/

 

Rising Prevalence of Cancer to Fuel Global Liquid Biopsy Market Growth

Liquid biopsy is a noninvasive diagnostic test that identifies various types of cancer. The increasing prevalence of cancer is leading to the growth of liquid biopsy market across the world. For instance, as per the American Cancer Society, Inc., in 2018, approximately 1.9 million new cancer cases and 693,000 cancer deaths were recorded in North America. Additionally, lung cancer remains the most common cause of death in both male and female. Rapid change in lifestyle and consumption of alcohol and tobacco products are the factors increasing the incidences of cancer among the population. Thus, increasing cancer prevalence across the globe is expected to drive the growth of the global liquid biopsy market.

 

Liquid Biopsy Market: Segmental Overview

 

Product & Services-Based Insights

The global liquid biopsy market, based on product & services, has been segmented into equipment, reagents & kits, and services. The reagents & kits segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period. The growth of reagents & kit segment is attributed to the enhancement of solution to improve staining results and unique antibodies with fluorescent staining markers. There are various reagent & kits available in market for the detection of cancerous cell. For instance, MagMAX cell-free total nucleic acid isolation kit is used to isolate and purify cfRNA and cfDNA from serum, plasma, or urine samples with the help of magnetic bead-based technology.

 

Liquid Biopsy Market: Competitive Landscape and Key Developments

Biocept, Inc.; Bio-Rad Laboratories, Inc.; Lunglifeai, Inc.; Exosome Diagnostics; F. Hoffmann-la Roche ltd; Inivata ltd; Exact sciences corporation, Mdxhealth; Qiagen; and Thermo fisher scientific Inc. are among the leading companies operating in the liquid biopsy market. Several companies are implementing organic strategies, such as products launch and expansions. Inorganic growth strategies witnessed in the market were partnerships and collaborations. These growth strategies have aided market players in expanding their businesses, geographical presence, strengthen customer base, and increase the product portfolio. The global liquid biopsy market size is anticipated to flourish with such developments by market players.

 

  • In March 2018, Thermo Fisher Scientific and Biocept entered into a commercial liquid biopsy partnership. The collaboration was likely to begin with the companies partnering to validate Thermo Fisher's Oncomine next-generation sequencing (NGS) liquid biopsy panels in Biocept's CLIA-certified laboratory.
  • In May 2017, F. HOFFMANN-LA ROCHE LTD launched a First blood-based distributed oncology tests covering all four mutation classes, namely AVENIO ctDNA Targeted Kit, Expanded Kit and Surveillance Kit. It is likely to give combine convenience of liquid biopsy with the power of next generation sequencing.

 

More Related Reports:

Generic Injectables Market

Surgical Retractors Market

Menstrual Cups Market

Cochlear Implants Market

 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Comments

Post a Comment

Popular posts from this blog

Frozen Food Market 2022 Industry Size, Share, Business Strategies, Emerging Technology, Product Portfolio, Countries Data and Demand Synopsis

  According to the new research study titled " Frozen Food Market to Forecast 2028 – COVID-19 Impact and Global Analysis – by Type, Distribution Channel, and Geography," the market is expected to grow from US$ 251,155.35 million in 2021 to US$ 373,767.59 million by 2028; it is expected to grow at a CAGR of 5.9% from 2022 to 2028. Over the past few years, the surge in the consumption of high-quality convenience food has been one of the biggest trends in the food industry. Convenience food, such as frozen snacks, frozen meals, cold cuts, and ready-to-eat products, allows consumers to save time and efforts associated with ingredient shopping, meal preparation and cooking, consumption, and post-meal activities. Due to hectic work schedules, millennials prefer to be efficient with their time rather than spending it on tedious tasks. Thus, they are more likely to spend their money on convenience food. Moreover, the growing number of one or two-person families can be related to t...
Read more

Orthopedic Braces and Supports Market Size 2020, Statistics, Trends, Regional Analysis by Key Players

  According to The Insight Partners market research study titled ‘ Orthopedic Braces and Supports Market to 2025 – Global Analysis and Forecasts by Product and Application. The global orthopedic braces and supports market is expected to reach US$ 5,429.3Mn in 2025 from US$ 3,631.2Mn in 2017. The market is estimated to grow with a CAGR of 5.3% from 2018-2025. The report highlights the trends prevalent in the global orthopedic braces and supports market and the factors driving the market. Global orthopedic braces and supports market, based on product was segmented into knee, back & hip, shoulder, elbow, foot and ankle and spine. In 2017, knee segment held the largest share of the market, by product. Whereas, the shoulder segment is reported to be the fastest growing of the market owing to the advantages provided by the braces such as providing support for the shoulder and the joint pains. Also the shoulder brace braces provides correct posture habits, keeps shoulder elevated t...
Read more